Triazolopyrimidine compounds and uses thereof
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein. 
Novartis AG
A A A A C A A A A
A61K A61K A61P A61K C07D A61K A61P A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Man Martin Yongfeng Xiang-Ju Justin Hailong Ho Man Yuan Wei Long Ling Ying Ji Yue (Jeff) Kehao Zhengtian Qiong
Zhang Sendzik Sun Gu Zhang Chan Mi Qi Wang Li Huang Zhang Zhao Yu Zhang